Literature DB >> 21346232

Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus.

Katsue Sunahori1, Yuang-Taung Juang, Vasileios C Kyttaris, George C Tsokos.   

Abstract

The catalytic subunit α isoform of protein phosphatase 2A (PP2Acα) activity, protein, and mRNA have been found increased in systemic lupus erythematosus (SLE) T cells and to contribute to decreased IL-2 production. The PP2Acα promoter activity is controlled epigenetically through the methylation of a CpG within a cAMP response element (CRE) motif defined by its promoter. We considered that hypomethylation may account for the increased expression of PP2Acα in patients with SLE. Using bisulfite sequencing, we found that SLE T cells displayed decreased DNA methylation in the promoter region compared with normal T cells. More importantly, we found that the CRE-defined CpG, which binds p-CREB, is significantly less methylated in SLE compared with normal T cells, and the levels of methylation correlated with decreased amounts of DNA methyltransferase 1 transcripts. Methylation intensity correlated inversely with levels of PP2Acα mRNA and SLE disease activity. Chromatin immunoprecipitation assays revealed more binding of p-CREB to the CRE site in SLE T cells, resulting in increased expression of PP2Acα. We propose that PP2Acα represents a new methylation-sensitive gene that, like the previously reported CD70 and CD11a, contributes to the pathogenesis of SLE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21346232      PMCID: PMC3148941          DOI: 10.4049/jimmunol.1000340

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

1.  Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness.

Authors:  Michael D Conkright; Ernesto Guzmán; Lawrence Flechner; Andrew I Su; John B Hogenesch; Marc Montminy
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

Review 2.  Abnormal T cell signal transduction in systemic lupus erythematosus.

Authors:  Gary M Kammer; Andras Perl; Bruce C Richardson; George C Tsokos
Journal:  Arthritis Rheum       Date:  2002-05

3.  Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells.

Authors:  Mariana J Kaplan; Qianjin Lu; Ailing Wu; John Attwood; Bruce Richardson
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

4.  Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients.

Authors:  C Deng; M J Kaplan; J Yang; D Ray; Z Zhang; W J McCune; S M Hanash; B C Richardson
Journal:  Arthritis Rheum       Date:  2001-02

Review 5.  Protein phosphatase 2A: variety of forms and diversity of functions.

Authors:  K Lechward; O S Awotunde; W Swiatek; G Muszyńska
Journal:  Acta Biochim Pol       Date:  2001       Impact factor: 2.149

Review 6.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.

Authors:  V Janssens; J Goris
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

Review 7.  Recent advances in MeCP2 structure and function.

Authors:  Kristopher C Hite; Valerie H Adams; Jeffrey C Hansen
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

Review 8.  Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus.

Authors:  Radosław Januchowski; Janusz Prokop; Paweł P Jagodziński
Journal:  J Appl Genet       Date:  2004       Impact factor: 3.240

9.  Possible role of DNA hypomethylation in the induction of SLE: relationship to the transcription of human endogenous retroviruses.

Authors:  H Ogasawara; M Okada; H Kaneko; T Hishikawa; I Sekigawa; H Hashimoto
Journal:  Clin Exp Rheumatol       Date:  2003 Nov-Dec       Impact factor: 4.473

10.  Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling.

Authors:  Chun Deng; Qianjin Lu; Zhiyong Zhang; Tharaknath Rao; John Attwood; Raymond Yung; Bruce Richardson
Journal:  Arthritis Rheum       Date:  2003-03
View more
  27 in total

Review 1.  Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Christian M Hedrich; George C Tsokos
Journal:  Trends Mol Med       Date:  2011-08-30       Impact factor: 11.951

Review 2.  The serine/threonine protein phosphatase 2A controls autoimmunity.

Authors:  Amir Sharabi; Isaac R Kasper; George C Tsokos
Journal:  Clin Immunol       Date:  2017-07-21       Impact factor: 3.969

3.  Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism.

Authors:  José C Crispín; Sokratis A Apostolidis; Florencia Rosetti; Marton Keszei; Ninghai Wang; Cox Terhorst; Tanya N Mayadas; George C Tsokos
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

Review 4.  Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus.

Authors:  Vasileios C Kyttaris; George C Tsokos
Journal:  Curr Opin Rheumatol       Date:  2011-09       Impact factor: 5.006

5.  DUSP23 is over-expressed and linked to the expression of DNMTs in CD4+ T cells from systemic lupus erythematosus patients.

Authors:  E Balada; L Felip; J Ordi-Ros; M Vilardell-Tarrés
Journal:  Clin Exp Immunol       Date:  2016-11-16       Impact factor: 4.330

6.  DNA methylation changes on immune cells in Systemic Lupus Erythematosus.

Authors:  Carolina Hurtado; Liliana Yazmín Acevedo Sáenz; Elsa María Vásquez Trespalacios; Rodrigo Urrego; Scott Jenks; Iñaki Sanz; Gloria Vásquez
Journal:  Autoimmunity       Date:  2020-02-04       Impact factor: 2.815

7.  Lupus autoimmunity altered by cellular methylation metabolism.

Authors:  Mei-Ling Yang; Alaric J P Gee; Renelle J Gee; Cecilia I Zurita-Lopez; Shilpi Khare; Steven G Clarke; Mark J Mamula
Journal:  Autoimmunity       Date:  2012-11-01       Impact factor: 2.815

Review 8.  DNA methylation alterations in the pathogenesis of lupus.

Authors:  S H Chen; Q L Lv; L Hu; M J Peng; G H Wang; B Sun
Journal:  Clin Exp Immunol       Date:  2016-11-01       Impact factor: 4.330

Review 9.  cAMP responsive element modulator: a critical regulator of cytokine production.

Authors:  Thomas Rauen; Christian M Hedrich; Klaus Tenbrock; George C Tsokos
Journal:  Trends Mol Med       Date:  2013-03-13       Impact factor: 11.951

10.  Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.

Authors:  Britta E Jones; Jiajin Yang; Akhil Muthigi; Susan L Hogan; Yichun Hu; Joshua Starmer; Candace D Henderson; Caroline J Poulton; Elizabeth J Brant; William F Pendergraft; J Charles Jennette; Ronald J Falk; Dominic J Ciavatta
Journal:  J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.